4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-22-009591
Options or other derivatives
- Director acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Patrick Kristin · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-15 | Grant or award : show line 1 in the form Stock Option (right to buy) | +40,000 | 40,000 | D |
Loading xslF345X03/wf-form4_165041444722067.xml…